• U.S. Burden of Skin and Subcutaneous Diseases Increasing

    Healthday News Conditions, HealthDay News Physician's Briefing June 25, 2020
  • Can dermatology employers require employees to receive the COVID-19 vaccine?

    American Academy of Dermatology AAD, Conditions, Coronavirus, COVID-19 January 28, 2021
  • THE 2020 VISION FOR NEMOLIZUMAB IN ATOPIC DERMATITIS

    American Academy of Dermatology AAD, Atopic Dermatitis, Conditions, Dermatology January 26, 2021
  • Expression of retinoid receptors in hand eczema.

    ClinOwl Atopic Dermatitis, ClinOwl, Conditions, Eczema October 1, 2020
  • S. aureus Agr Virulence Tied to Atopic Dermatitis in Infants

    Healthday News Atopic Dermatitis, Conditions, Eczema July 28, 2020
  • Psoriasis, biological drugs and Coronavirus Disease 2019: Real life experience of two Italian provinces.

    ClinOwl ClinOwl, Conditions, COVID-19, Psoriasis July 26, 2020

DermConnect® is an official licensee of the American Academy of Dermatology.

DermConnect®
Navigation
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma
Home 2020 September 22

Post Archive by Day

Children of the Sun: a historical look at how pediatric light therapy shaped attitudes and behaviors toward sunbathing.

In Dermatology
by ClinOwl
September 22, 2020

Today, parents are warned to protect their children from the sun’s ultraviolet (UV) rays, the most preventable and leading cause of skin cancer. Yet, during the first half of the …

Overlap between hemophagocytic lymphohistiocytosis and drug reaction and eosinophilia with systemic symptoms: a review.

In Dermatology
by ClinOwl
September 22, 2020

Drug reaction and eosinophilia with systemic symptoms (DRESS), also known as drug-induced hypersensitivity syndrome (DIHS), shares features with hemophagocytic lymphohistiocytosis (HLH), most notably fever, rash, and internal organ involvement. However, …

View Post

Individuals With Diabetes Have Increased Risk for Falls

In HealthDay News
by Healthday
September 22, 2020

Risk for falls higher in adjusted analysis for individuals with type 1 and type 2 diabetes

View Post

Study Examines Effect of Cancer Treatment on COVID-19 Mortality

In HealthDay News
by Healthday
September 22, 2020

Highest 30-day mortality seen with cancer treatment one to three months before COVID-19 diagnosis

View Post

Pregnancy May Delay Onset of Multiple Sclerosis Symptoms

In HealthDay News
by Healthday
September 22, 2020

However, having more pregnancies not associated with later onset

View Post

Glucocorticoids Linked to Hospitalized Infection Risk in RA

In HealthDay News
by Healthday
September 22, 2020

Risk for hospitalized infections up for patients with RA receiving DMARDs with continued glucocorticoid use

View Post

Mental Illness Recognition Up in U.K. General Hospital Admissions

In HealthDay News
by Healthday
September 22, 2020

Diagnostic recording less accurate for those with minority ethnicity, married status, better health

View Post

Air Pollution May Raise Stroke Risk With Atrial Fibrillation

In HealthDay News
by Healthday
September 22, 2020

Findings account for neighborhood-specific pollution data, sociodemographic factors

View Post

Loneliness a Risk Factor for Type 2 Diabetes Mellitus

In HealthDay News
by Healthday
September 22, 2020

Findings independent of known diabetes risk factors, depression, living alone, social isolation

View Post

PrEP Prescribing Low in the U.S., Even Among HIV Care Providers

In HealthDay News
by Healthday
September 22, 2020

About half of survey participants recruited from HIV CME courses reported ever prescribing PrEP

  • Page 1 of 2
  • 1
  • 2
  • →

TRENDING

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease
  • Lymph Node Dissection Declining in SLN-Positive Melanoma
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

LATEST ARTICLES

  • Dose Range for Iberdomide Studied in Systemic Lupus Erythematosus March 16, 2022
  • YouTube Video Quality for Aesthetic Injectables Lower Than Quality of Websites March 11, 2022
  • Cardiac Biomarkers and CV Risk Examined in Psoriatic Disease March 11, 2022
  • Lymph Node Dissection Declining in SLN-Positive Melanoma March 9, 2022
  • Debt Valuation of Private Equity-Backed Dermatology Groups Down March 9, 2022

Quick Links

  • Home
  • Atopic Dermatitis
  • Psoriasis
    • Chronic Plaque Psoriasis
    • Guttate Psoriasis
  • Skin Cancer
    • Basal Cell Carcinoma
    • Cutaneous T-cell Lymphoma
    • Dermatofibrosarcoma Protuberans (DFSP)
    • Melanoma
    • Merkel Cell Carcinoma
    • Sebaceous Carcinoma
    • Squamous Cell Carcinoma

About DermConnect®

DermConnect® curates the latest in dermatology news and resources from some of the most trusted and respected names in healthcare, including the American Academy of Dermatology, ClinOwl, HealthDay and Dermnet NZ.

SCHEDULE

September 2020
M T W T F S S
 123456
78910111213
14151617181920
21222324252627
282930  
« Jul   Oct »

All content indicated on this website as authored by "AAD" is owned by and licensed with the permission of the American Academy of Dermatology (“AAD”) for personal educational use.

The content may not be distributed in whole or in part to any third parties without express written permission from AAD,
nor may viewers of this site translate, edit, modify or otherwise create derivative works from the content.

The licensing of the content by AAD does not constitute or imply any endorsement of any company and/or any of its goods, services or written work product.

 

  • Home
  • Atopic Dermatitis
  • Psoriasis
  • Skin Cancer